
BioNano Genomics BNGO
$ 1.14
-0.87%
Annual report 2025
added 03-23-2026
BioNano Genomics Operating Cycle 2011-2026 | BNGO
Annual Operating Cycle BioNano Genomics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 315 | 329 | 477 | 430 | 281 | 330 | 414 | 182 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 477 | 182 | 345 |
Quarterly Operating Cycle BioNano Genomics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 263 | 351 | 377 | - | 211 | 499 | 486 | - | 538 | 547 | 622 | - | 248 | 180 | 354 | - | 238 | 207 | 205 | - | 323 | 716 | 726 | 393 | 307 | 468 | 447 | 135 | 177 | 175 | 353 | 211 | 101 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 726 | 101 | 352 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Biodesix
BDSX
|
41.7 | $ 14.1 | -3.46 % | $ 1.83 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
91.7 | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Sotera Health Company
SHC
|
80.3 | $ 13.29 | -1.88 % | $ 3.77 B | ||
|
Soleno Therapeutics
SLNO
|
1.04 K | $ 29.99 | -5.78 % | $ 1.52 B | ||
|
Neuronetics
STIM
|
69.1 | $ 1.44 | 8.27 % | $ 95 M | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
Thermo Fisher Scientific
TMO
|
70 | $ 478.51 | -2.12 % | $ 180 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.6 | -2.2 % | $ 61.9 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 45.31 | -3.08 % | $ 2.71 B | ||
|
Co-Diagnostics
CODX
|
405 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
Waters Corporation
WAT
|
834 | $ 292.64 | -2.64 % | $ 17.4 B | ||
|
National Research Corporation
NRC
|
29.4 | $ 17.16 | -1.15 % | $ 384 M | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
Charles River Laboratories International
CRL
|
65 | $ 158.44 | -4.05 % | $ 7.85 B | ||
|
Exagen
XGN
|
51.2 | $ 2.67 | -4.3 % | $ 57.6 M | ||
|
Organovo Holdings
ONVO
|
79.8 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
4.66 | - | -16.95 % | $ 1.54 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
ENDRA Life Sciences
NDRA
|
412 | $ 4.65 | 1.31 % | $ 2.5 M | ||
|
Personalis
PSNL
|
55.8 | $ 6.68 | -8.76 % | $ 396 M | ||
|
PerkinElmer
PKI
|
92.2 | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
368 | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
79.2 | $ 1.73 | 2.37 % | $ 7.59 M | ||
|
RadNet
RDNT
|
34.5 | $ 57.44 | -3.32 % | $ 4.32 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
172 | - | - | $ 10.6 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Senseonics Holdings
SENS
|
104 | $ 6.54 | -0.38 % | $ 273 M | ||
|
Laboratory Corporation of America Holdings
LH
|
71.8 | $ 268.45 | 0.03 % | $ 22.3 B | ||
|
VolitionRx Limited
VNRX
|
52.3 | $ 0.2 | 3.52 % | $ 19.2 M | ||
|
Psychemedics Corporation
PMD
|
61.3 | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
49.8 | $ 26.48 | -2.65 % | $ 34.4 M | ||
|
CareDx, Inc
CDNA
|
51.5 | $ 17.08 | -2.23 % | $ 910 M | ||
|
Quotient Limited
QTNT
|
432 | - | -11.32 % | $ 1.1 M | ||
|
Syneos Health
SYNH
|
102 | - | - | $ 4.46 B | ||
|
Renalytix AI plc
RNLX
|
15.9 | - | 5.66 % | $ 22.7 M |